Guidance for WuXi PharmaTech (WX)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2015 | $1.73 – $1.75 | $2.10 | $790.00M – 800.00M | $779.57M | Lowered | Details |
Q2 2015 | $0.38 – $0.40 | $0.42 | $194.00M – 196.00M | $193.60M | = Maintained | Details |
2014 | $1.80 – $1.85 | $1.96 | $660.00M – 670.00M | $669.18M | = Maintained | Details |
2014 | $1.83 – $1.86 | $1.84 | $670.00M – 672.00M | $671.47M | Raised | Details |
2014 | $1.95 – $2.00 | $1.90 | $660.00M – 670.00M | $666.10M | = Maintained | Details |
2014 | $1.82 – $1.86 | $1.84 | $665.00M – 670.00M | $669.74M | Raised | Details |
Q2 2014 | $0.46 – $0.48 | $0.49 | $160.00M – 162.00M | $164.45M | = Maintained | Details |
2013 | $1.49 – $1.53 | $1.44 | $565.00M – 575.00M | $571.58M | = Maintained | Details |
Q2 2013 | $0.39 – $0.40 | $0.36 | $138.00M – 140.00M | $142.30M | = Maintained | Details |
2012 | N/A | N/A | $488.00M – 498.00M | $484.30M | Raised | Details |
2012 | N/A | N/A | $468.00M – 488.00M | $464.60M | = Maintained | Details |
2012 | N/A | N/A | $495.00M – 498.00M | $485.00M | Raised | Details |
Q4 2012 | N/A | N/A | $121.00M – 124.00M | $119.73M | = Maintained | Details |
Q3 2012 | N/A | N/A | $121.00M – 124.00M | $119.73M | = Maintained | Details |
Q2 2012 | N/A | N/A | $124.00M – 129.00M | $118.03M | = Maintained | Details |
Q1 2012 | N/A | N/A | $114.00M – 117.00M | $108.00M | = Maintained | Details |
2011 | N/A | N/A | $390.00M – 405.00M | $395.52M | = Maintained | Details |
2011 | N/A | N/A | $400.00M – 407.00M | $400.89M | = Maintained | Details |
2011 | N/A | N/A | $402.00M – 406.00M | $405.23M | = Maintained | Details |
Q3 2011 | N/A | N/A | $100.00M – 103.00M | $101.17M | = Maintained | Details |
Q2 2011 | N/A | N/A | $97.00M – 99.00M | $99.10M | = Maintained | Details |